Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001683168-25-005402
Filing Date
2025-07-25
Accepted
2025-07-25 16:00:59
Documents
24

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT actuate_s1.htm   iXBRL S-1 321960
2 OPINION OF BAKER & HOSTETLER LLP actuate_ex0501.htm EX-5.1 8700
3 CONSENT OF CROWE LLP actuate_ex2301.htm EX-23.1 2921
4 CONSENT OF KMJ CORBIN & COMPANY LLP actuate_ex2302.htm EX-23.2 2797
5 FILING FEE IXBRL actuate_ex107.htm   iXBRL EX-FILING FEES 13231
6 GRAPHIC image_001.jpg GRAPHIC 2403
7 GRAPHIC image_002.jpg GRAPHIC 5334
8 GRAPHIC image_003.jpg GRAPHIC 10373
  Complete submission text file 0001683168-25-005402.txt   733721

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE actu-20250725.xsd EX-101.SCH 3047
10 XBRL LABEL FILE actu-20250725_lab.xml EX-101.LAB 34766
11 XBRL PRESENTATION FILE actu-20250725_pre.xml EX-101.PRE 22738
26 EXTRACTED XBRL INSTANCE DOCUMENT actuate_s1_htm.xml XML 3124
27 EXTRACTED XBRL INSTANCE DOCUMENT actuate_ex107_htm.xml XML 4459
Mailing Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 847-986-4190
ACTUATE THERAPEUTICS, INC. (Filer) CIK: 0001652935 (see all company filings)

EIN.: 473044785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-288952 | Film No.: 251151623
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)